MT Weekly: Surprising Opioid Stats, HIV Research Strides and Stalled Zofran Litigation

Image for post
Image for post

Innovations in HIV treatment

The National Institute of Health has announced earlier this month that they are committing $129 million to HIV research led by Scripps Research.

Zofran’s Litigation

GlaxoSmithKline (GSK) requested that the U.S. Food and Drug Administration (FDA) release a statement reporting the claims of hundreds of Zofran lawsuits against them.

Monitoring The Opioid Crisis

In a federal report released Wednesday, promising numbers were released amid the opioid crisis. According to a report on Medicare beneficiaries provided by Kaiser Health News:

  • The number of beneficiaries at risk for overdose is down by 46%
  • The number of doctors prescribing opioids to at-risk patients is down by 51%

Breast Implant Bans

Though the U.S. Food and Drug Administration (FDA) has yet to conclusively state whether textured breast implants place women’s health at risk, individuals and organizations across the world are taking action.

Image for post
Image for post

James Parker

James Parker is a content writer from Coral Springs, Florida. He majored in Communication and Media Studies at Stetson University, where he spent much of his time bringing the cutting edge of medical research to his peers’ attention. When he’s not writing, he enjoys rewatching “Almost Famous” or curling up with a good book.

MedTruth is a digital magazine reporting on health, safety and justice. Join the revolution today at

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store